Publications by authors named "Vance Warren"

Claim this Profile
M
Metabolism, excretion, and pharmacokinetics of [C]mirogabalin, a novel αδ ligand, in healthy volunteers following oral administration.
Naotoshi Yamamura, Jeanne Mendel-Harary, Karen Brown, Minoru Uchiyama, Yoko Urasaki, Vance Warren

Xenobiotica· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of DS-1040 Drug-Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin.
Tharin Limsakun, Victor Dishy, Jeanne Mendell, Flavia Pizzagalli, Joseph Pav, Vance Warren

J Clin Pharmacol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of an Oral Formulation of DS-1040, an Inhibitor of the Activated Form of Thrombin-Activatable Fibrinolysis Inhibitor, in Healthy Subjects.
Jin Zhou, Tharin Limsakun, Ophelia Yin, Vance Warren, Cynthia Zamora

J Clin Pharmacol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects.
Yutaro Maekawa, Hidetoshi Furuie, Manabu Kato, Yusuke Myobatake, Emi Kamiyama, Vance Warren

Clin Drug Investig· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse potential of mirogabalin in recreational polydrug users.
Jeanne Mendell, Naama Levy-Cooperman, Ed Sellers, Bradley Vince, Debra Kelsh, Vance Warren

Ther Adv Drug Saf· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-Label Single-Dose Study to Assess the Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics of Mirogabalin.
Kenneth Duchin, Giorgio Senaldi, Vance Warren, Thomas Marbury, Kenneth Lasseter

Clin Drug Investig· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coadministration of probenecid and cimetidine with mirogabalin in healthy subjects: A phase 1, randomized, open-label, drug-drug interaction study.
Masaya Tachibana, Naotoshi Yamamura, George J Atiee, Ching Hsu, Vance Warren

Br J Clin Pharmacol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability, pharmacokinetics, and pharmacodynamics of mirogabalin in healthy subjects: Results from phase 1 studies.
Karen Brown, Jeanne Mendell, Shoichi Ohwada, Ching Hsu, Ling He, Vance Warren

Pharmacol Res Perspect· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Oral Doses of DS-3801b, a Motilin Receptor Agonist, in Healthy Subjects.
Justin Dennie, George Atiee, Vance Warren, Ben Tao, Kiyoshi Morimoto

J Clin Pharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
Sujata Vaidyanathan, Mojdeh Maboudian, Vance Warren, Ching-Ming Yeh, Hans Armin Dieterich

Curr Med Res Opin· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of the oral Renin inhibitor aliskiren in patients with hepatic impairment.
Sujata Vaidyanathan, Vance Warren, Chingming Yeh, Marie-Noelle Bizot, Hans Armin Dieterich

J Clin Pharmacol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis